4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001789335-26-000004
Director acquired 3,166 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Chan Mitchell · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-28 | Exercise or conversion : show line 1 in the form | +3,166 | 6,333 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-28 | Exercise or conversion : show line 2 in the form Restricted Stock Units | −3,166 | 3,167 | D |
Loading xslF345X06/form4-03312026_080349.xml…